Benitec Biopharma Inc. (BNTC) Financials

NASDAQ Currency in USD Disclaimer

$11.58

north_east $0.34 (3.02%)
Day's range
$11.23
Day's range
$11.75

BNTC Income statement / Annual

Last year (2024), Benitec Biopharma Inc.'s total revenue was $216,000.00, an increase of 188.00% from the previous year. In 2024, Benitec Biopharma Inc.'s net income was -$21.75 M. See Benitec Biopharma Inc.�s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015
Period Ended 06/30/2024 06/30/2023 06/30/2022 06/30/2021 06/30/2020 06/30/2019 06/30/2018 06/30/2017 06/30/2016 06/30/2015
Operating Revenue $216,000.00 $75,000.00 $73,000.00 $59,000.00 $97,000.00 $11.32 M $455,446.00 $450,311.00 $346,506.00 $829,127.00
Cost of Revenue $108,000.00 $381,000.00 $9,000.00 $123,000.00 $268,065.00 $426,506.00 $331,300.00 $209,018.00 $103,802.00 $30,680.00
Gross Profit $108,000.00 -$306,000.00 $64,000.00 -$64,000.00 -$171,065.00 $10.89 M $124,146.00 $241,293.00 $242,704.00 $798,447.00
Gross Profit Ratio 0.5 -4.08 0.88 -1.08 -1.76 0.96 0.27 0.54 0.7 0.96
Research and Development Expenses $15.61 M $12.77 M $11.27 M $7.02 M $3.00 M $2.17 M $5.06 M $5.32 M $9.92 M $4.78 M
General & Administrative Expenses $6.71 M $6.38 M $6.65 M $6.51 M $5.57 M $6.66 M $6.41 M $6.99 M $8.96 M $6.17 M
Selling & Marketing Expenses $277,000.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $6.99 M $6.38 M $6.65 M $6.51 M $5.57 M $6.66 M $6.41 M $6.99 M $8.96 M $6.17 M
Other Expenses -$216,000.00 -$30,000.00 -$79,000.00 $37,000.00 -$5,000.00 $154,774.00 $734.59 -$7.91 M -$2.68 M -$2.14 M
Operating Expenses $22.38 M $19.16 M $17.92 M $13.53 M $8.56 M $8.99 M $8.68 M $4.40 M $16.20 M $8.80 M
Cost And Expenses $22.49 M $19.16 M $17.93 M $13.66 M $8.38 M $9.41 M $9.01 M $4.61 M $16.31 M $8.84 M
Interest Income $0.00 $49,546.00 $46,348.00 $0.00 $62,000.00 $119,057.00 $0.00 $0.00 $0.00 $0.00
Interest Expense $904,000.00 $33,000.00 $32,000.00 $6,000.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Depreciation & Amortization $0.00 $381,000.00 $392,000.00 $424,000.00 $374,000.00 $154,774.00 $142,510.00 $166,753.00 $11.54 M $74,399.00
EBITDA -$22.49 M -$18.70 M -$17.85 M -$13.60 M -$7.91 M $2.74 M -$8.59 M -$4.19 M -$13.42 M -$7.93 M
EBITDA Ratio -104.12 -249.73 -245.66 -225.07 -80.6 0.19 -18.47 -8.41 -38.72 -8.58
Operating Income Ratio -104.12 -254.41 -244.58 -230.44 -85.37 0.18 -18.78 -35.36 -72.04 -16.08
Total Other Income/Expenses Net $120,000.00 -$481,000.00 -$354,000.00 -$286,000.00 $7,000.00 $606,031.00 $179,240.00 $11.55 M $6.46 M $4.50 M
Income Before Tax -$22.37 M -$19.56 M -$18.21 M -$13.88 M -$8.27 M $2.87 M -$8.55 M -$4.37 M -$18.50 M -$8.83 M
Income Before Tax Ratio -103.56 -260.83 -249.42 -235.29 -85.3 0.25 -18.77 -9.71 -53.4 -10.65
Income Tax Expense -$619,000.00 $3,000.00 $354,000.00 -$101,000.00 $27,000.00 -$864,218.28 $1,469.18 $209,786.00 -$9.00 M $821,457.00
Net Income -$21.75 M -$19.56 M -$18.56 M -$13.78 M -$8.30 M $2.87 M -$8.55 M -$4.37 M -$18.50 M -$8.83 M
Net Income Ratio -100.7 -260.83 -254.27 -233.58 -85.58 0.25 -18.77 -9.71 -53.4 -10.65
EPS -5.36 -14.12 -38.62 -54.54 -138.19 56.89 -207.21 -127.11 -663.12 -389.77
EPS Diluted -5.36 -14.12 -38.62 -54.54 -138.19 56.89 -207.21 -127.11 -663.12 -389.77
Weighted Average Shares Out $4.06 M $1.39 M $480,688.00 $252,671.00 $60,070.00 $50,398.00 $41,265.00 $34,398.00 $27,904.00 $22,648.00
Weighted Average Shares Out Diluted $4.06 M $1.39 M $480,688.00 $252,670.00 $60,070.00 $50,398.00 $41,266.00 $34,399.00 $27,904.00 $22,648.00
Link